Rockefeller Capital Management L.P. - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 164 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$72
-20.9%
14,702
+0.5%
0.00%
Q4 2022$91
-99.9%
14,625
+3.8%
0.00%
-100.0%
Q3 2022$151,000
+3.4%
14,083
+9.7%
0.00%0.0%
Q2 2022$146,000
-60.4%
12,835
-68.4%
0.00%
-50.0%
Q1 2022$369,000
-24.1%
40,589
+24.3%
0.00%0.0%
Q4 2021$486,000
+89.1%
32,646
+226.5%
0.00%
+100.0%
Q3 2021$257,000
+233.8%
10,000
+227.4%
0.00%0.0%
Q4 2020$77,0003,0540.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$5,700,1778.82%
Wildcat Capital Management, LLC 1,920,787$6,088,8952.44%
TPG GP A, LLC 18,716,306$59,330,6901.02%
EcoR1 Capital, LLC 4,488,200$14,227,5940.48%
CROSSPOINT FINANCIAL, LLC 12,000$38,0400.40%
Coastal Bridge Advisors, LLC 406,847$1,289,7050.35%
CAXTON ASSOCIATES LP 480,104$1,521,9300.21%
Woodline Partners LP 5,313,915$16,845,1110.20%
Rhenman & Partners Asset Management AB 300,000$951,0000.10%
Navalign, LLC 75,365$238,9070.09%
View complete list of ALLOGENE THERAPEUTICS INC shareholders